600479ZhuZhou QianJin Pharmaceutical600479 info
$1.32info-0.11%24h
Global rank10695
Market cap$566.38M
Change 7d-6.22%
YTD Performance-13.35%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    ZhuZhou QianJin Pharmaceutical (600479) Stock Overview

    ZhuZhou QianJin Pharmaceutical Co.,Ltd researches, produces, and sells Chinese patent medicines, chemical medicines, and feminine hygiene products in China. The company offers traditional Chinese medicine products, including fuke qianjin capsules, chunru gel, buxue yimu pills and granules, fuke duanhongyin capsules, yimu granules, qianjin zhidai pills, fuke tiaojing tablets, jiawei xiaoyao pills, rupikang capsules, lingzhi syrup, xiao'er ganmao granules, fenghan ganmao granules, shujin fengshi medicinal liquor, and shiguogong medicinal liquor; and women's health derivatives, such as qianjin jingya sanitary napkin, qianjin run washing, and care series, etc. It also provides hygienic products, including gynaecological nursing, maternity pad/ maternity package, and baby nursing. In addition, the company provides ginger tea and wine. Additionally, it covers gynecology, cardiovascular system, endocrine system, nervous, antiviral, psychiatric, tonic, and other fields. ZhuZhou QianJin Pharmaceutical Co.,Ltd was founded in 1966 and is headquartered in Zhuzhou, China.

    600479 Stock Information

    Symbol
    600479
    Address
    No. 801 Zhuzhou AvenueZhuzhou, 412000China
    Founded
    -
    Trading hours
    9:30 AM - 3:00 PM CST
    Website
    https://www.qjyy.com
    Country
    🇨🇳 China
    Phone Number
    86 731 2249 0083

    ZhuZhou QianJin Pharmaceutical (600479) Price Chart

    -
    Value:-

    ZhuZhou QianJin Pharmaceutical Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $1.32
    N/A
    Market Cap
    $566.38M
    N/A
    Shares Outstanding
    428.92M
    N/A
    Employees
    5.13K
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org